Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-19-019555)

Filing Details

Accession Number:: 0001127602-19-019555
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-05-23 12:59:02
Reporting Period:: 2019-05-22

Accepted Time:: 2019-05-23 12:59:02
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
794172	Meridian Bioscience Inc	VIVO	In Vitro & In Vivo Diagnostic Substances (2835)	310888197

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1714030	Jr. Mccune John Rice	3471 River Hills Drive Cincinnati OH 45244		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2019-05-22	981	$0.00	0	No	4	J	Direct
Common Stock	Acquisiton	2019-05-22	981	$0.00	3,981	No	4	J	Direct
Common Stock	Acquisiton	2019-05-22	2,000	$11.26	5,981	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	J	Direct
No	4	J	Direct
No	4	P	Direct

Footnotes

Following the January 24, 2019 grant of 981 restricted stock units (as reported on Form 4 filed January 28, 2019), Direct Common Stock holdings totaled 3,981.